Healthcare companies by risk reading
Healthcare companies by risk reading: 1,695 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 21 October 2026.
Composite readings for 14,899 companies, recomputed 21 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Euromedis Groupe SA ALEMG | 34 | Normal | Healthcare | France | 4 / 6 | $18M |
| Concord Medical Services CCM | 44 | Elevated | Healthcare | China | 5 / 6 | $18M |
| Scilex Holding Company SCLX | 82 | Acute | Healthcare | United States | 4 / 6 | $18M |
| Perseus Proteomics Inc. 4882.T | 54 | Elevated | Healthcare | Japan | 4 / 6 | $18M |
| EUROPEAN MEDICAL SOLUTIONS ALEMS | 25 | Normal | Healthcare | Belgium | 5 / 6 | $17M |
| Retractable Technologies Inc RVP | 56 | Elevated | Healthcare | United States | 5 / 6 | $17M |
| Biosynex ALBIO | 68 | Stretched | Healthcare | France | 5 / 6 | $17M |
| Atyr Pharma Inc ATYR | 81 | Acute | Healthcare | United States | 5 / 6 | $17M |
| Accuray Inc ARAY | 48 | Elevated | Healthcare | United States | 6 / 6 | $17M |
| Cytosorbents Corp CTSO | 58 | Elevated | Healthcare | United States | 3 / 6 | $17M |
| Republic Healthcare Limited 8357.HK | 54 | Elevated | Healthcare | Singapore | 5 / 6 | $17M |
| PuraPharm Corporation Limited 1498.HK | 48 | Elevated | Healthcare | Hong Kong | 5 / 6 | $16M |
| Proteomics International Laboratories Ltd PIQ | 73 | Stretched | Healthcare | Australia | 4 / 6 | $16M |
| 111 Inc YI | 45 | Elevated | Healthcare | China | 5 / 6 | $16M |
| Grand Brilliance Group Holdings Limited 8372.HK | 29 | Normal | Healthcare | Hong Kong | 5 / 6 | $16M |
| Hybrigenics Societe Anonyme ALTAO.PA | 59 | Elevated | Healthcare | France | 5 / 6 | $16M |
| Jin Medical International Ltd ZJYL | 58 | Elevated | Healthcare | China | 5 / 6 | $16M |
| Rewalk Robotics Ltd LFWD | 57 | Elevated | Healthcare | Israel | 5 / 6 | $16M |
| Biotechnology Assets, S.A. BST.MC | 42 | Elevated | Healthcare | Spain | 5 / 6 | $16M |
| Emergency Assistance Japan Co., Ltd. 6063.T | 35 | Normal | Healthcare | Japan | 5 / 6 | $16M |
| ALTAO ALTAO | 59 | Elevated | Healthcare | France | 5 / 6 | $16M |
| Quantum Cyber N.V. QUCY | 70 | Stretched | Healthcare | Germany | 5 / 6 | $16M |
| D & M Company Co., Ltd. 189A.T | 37 | Normal | Healthcare | Japan | 5 / 6 | $16M |
| Welby Inc. 4438.T | 49 | Elevated | Healthcare | Japan | 5 / 6 | $16M |
| BioCardia Inc BCDA | 66 | Stretched | Healthcare | United States | 3 / 6 | $16M |
| P3 Health Partners Inc - Class A PIII | 54 | Elevated | Healthcare | United States | 4 / 6 | $16M |
| OTOFARMA OTO.MI | 25 | Normal | Healthcare | Italy | 4 / 6 | $15M |
| AsiaMedic Limited 505.SI | 21 | Normal | Healthcare | Singapore | 4 / 6 | $15M |
| ImpediMed Limited IPD.AX | 55 | Elevated | Healthcare | United States | 4 / 6 | $15M |
| SKINBIO THERAP LS-01 5KW | 33 | Normal | Healthcare | United Kingdom | 5 / 6 | $15M |
| Tscan Therapeutics Inc TCRX | 63 | Stretched | Healthcare | United States | 5 / 6 | $15M |
| Thalia Therapeutics Plc THAT | 60 | Stretched | Healthcare | United Kingdom | 3 / 6 | $15M |
| Baird Medical Investment Holdings Ltd . BDMD | 78 | Stretched | Healthcare | China | 5 / 6 | $15M |
| Bionano Genomics Inc BNGO | 56 | Elevated | Healthcare | United States | 4 / 6 | $15M |
| Aptamer Group PLC APTA | 76 | Stretched | Healthcare | United Kingdom | 5 / 6 | $15M |
| Wanjia Group Holdings Limited 0401.HK | 32 | Normal | Healthcare | Hong Kong | 5 / 6 | $15M |
| FunPep Company Limited 4881.T | 94 | Acute | Healthcare | Japan | 3 / 6 | $14M |
| EUKEDOS EUK.MI | 42 | Elevated | Healthcare | Italy | 5 / 6 | $14M |
| Inoviq Ltd IIQ | 37 | Normal | Healthcare | Australia | 4 / 6 | $14M |
| Dyadic International Inc DE DYAI | 73 | Stretched | Healthcare | United States | 4 / 6 | $14M |
| PAVmed Inc PAVM | 86 | Acute | Healthcare | United States | 5 / 6 | $14M |
| Allarity Therapeutics Inc ALLR | 70 | Stretched | Healthcare | United States | 4 / 6 | $14M |
| Intrasense ALINS | 82 | Acute | Healthcare | France | 4 / 6 | $14M |
| Veritas In Silico Inc. 130A.T | 82 | Acute | Healthcare | Japan | 4 / 6 | $14M |
| Observe Medical Asa OBSRV | 68 | Stretched | Healthcare | Norway | 5 / 6 | $14M |
| Lipocine Inc LPCN | 39 | Normal | Healthcare | United States | 4 / 6 | $13M |
| IRIDEX Corp IRIX | 46 | Elevated | Healthcare | United States | 5 / 6 | $13M |
| Geratherm Medical AG GME.DE | 40 | Elevated | Healthcare | Germany | 5 / 6 | $13M |
| SeaStar Medical Holding Corp ICU | 48 | Elevated | Healthcare | United States | 4 / 6 | $13M |
| CelLBxHealth plc CLBX | 60 | Stretched | Healthcare | United Kingdom | 5 / 6 | $13M |
| ReShape Lifesciences Inc HIND | 73 | Stretched | Healthcare | United States | 3 / 6 | $13M |
| Poxel SA POXEL | 41 | Elevated | Healthcare | France | 3 / 6 | $13M |
| Algorae Pharmaceuticals Ltd 1AI | 92 | Acute | Healthcare | Australia | 3 / 6 | $13M |
| Genetic Signatures Limited GSS.AX | 67 | Stretched | Healthcare | Australia | 4 / 6 | $13M |
| Painchek Ltd PCK | 43 | Elevated | Healthcare | Australia | 3 / 6 | $13M |
| CodeLab Capital AS CODE.OL | 82 | Acute | Healthcare | Norway | 4 / 6 | $12M |
| Artra Group Corporation 6029.T | 32 | Normal | Healthcare | Japan | 5 / 6 | $12M |
| New Century Healthcare Holding Co. Limited 1518.HK | 53 | Elevated | Healthcare | China | 5 / 6 | $12M |
| EZZ Life Science Holdings Ltd EZZ | 17 | Contained | Healthcare | Australia | 4 / 6 | $12M |
| Heart Test Laboratories Inc HSCS | 77 | Stretched | Healthcare | United States | 5 / 6 | $12M |
| VIDAVO S.A. VIDAVO | 24 | Normal | Healthcare | Greece | 5 / 6 | $12M |
| Ziyuanyuan Holdings Group Limited 8223.HK | 36 | Normal | Healthcare | China | 4 / 6 | $12M |
| ANGLE plc DWV | 57 | Elevated | Healthcare | United Kingdom | 4 / 6 | $12M |
| Intelicare Holdings Ltd ICR | 51 | Elevated | Healthcare | Australia | 4 / 6 | $12M |
| Livingstone Health Holdings Limited PRH.SI | 36 | Normal | Healthcare | Singapore | 5 / 6 | $12M |
| Observe Medical ASA OM50 | 68 | Stretched | Healthcare | Norway | 5 / 6 | $12M |
| Kelfred Holdings Limited 1134.HK | 35 | Normal | Healthcare | Hong Kong | 5 / 6 | $12M |
| Syra Health Corp - Class A SYRA | 50 | Elevated | Healthcare | United States | 5 / 6 | $12M |
| Joyzyme Group Limited 8622.HK | 54 | Elevated | Healthcare | Hong Kong | 5 / 6 | $12M |
| IDT Australia Limited IDT.AX | 21 | Normal | Healthcare | Australia | 4 / 6 | $11M |
| Imexhs Ltd IME | 29 | Normal | Healthcare | Australia | 4 / 6 | $11M |
| Pulsenmore Ltd PLSM | 33 | Normal | Healthcare | Israel | 5 / 6 | $11M |
| Biofrontera Inc BFRI | 36 | Normal | Healthcare | United States | 5 / 6 | $11M |
| SINTX Technologies Inc SINT | 75 | Stretched | Healthcare | United States | 4 / 6 | $11M |
| Petgo Corporation 7140.T | 54 | Elevated | Healthcare | Japan | 5 / 6 | $11M |
| Cambium Bio Ltd CMB | 69 | Stretched | Healthcare | Australia | 3 / 6 | $11M |
| Advicenne ALDVI | 59 | Elevated | Healthcare | France | 5 / 6 | $11M |
| Atomo Diagnostics Limited AT1.AX | 33 | Normal | Healthcare | Australia | 4 / 6 | $11M |
| Glycorex Transplantation AB (publ) O33 | 28 | Normal | Healthcare | Sweden | 4 / 6 | $11M |
| Recovery International Co.,Ltd. 9214.T | 20 | Normal | Healthcare | Japan | 5 / 6 | $11M |
| Dare Bioscience Inc DARE | 64 | Stretched | Healthcare | United States | 5 / 6 | $10M |
| CytoMed Therapeutics Ltd GDTC | 54 | Elevated | Healthcare | Singapore | 5 / 6 | $10M |
| OPTHEA LTD UKJ | 76 | Stretched | Healthcare | Australia | 3 / 6 | $10M |
| MDxHealth SA MDXH | 39 | Normal | Healthcare | Belgium | 5 / 6 | $10M |
| CRISM Therapeutics Corporation CRTX | 53 | Elevated | Healthcare | British Virgin Islands | 3 / 6 | $10M |
| Scandinavian Medical Solutions AS SMSMED | 42 | Elevated | Healthcare | Denmark | 5 / 6 | $10M |
| Pluri Inc PLUR | 62 | Stretched | Healthcare | Israel | 5 / 6 | $10M |
| Caring Brands Inc CABR | 82 | Acute | Healthcare | United States | 3 / 6 | $10M |
| Bioline Rx Ltd BLRX | 76 | Stretched | Healthcare | Israel | 5 / 6 | $10M |
| Lisata Therapeutics Inc LSTA | 62 | Stretched | Healthcare | United States | 4 / 6 | $9M |
| ReNerve Limited RNV.AX | 36 | Normal | Healthcare | Australia | 4 / 6 | $9M |
| Spineguard ALSGD | 56 | Elevated | Healthcare | France | 5 / 6 | $9M |
| Ligua Inc. 7090.T | 40 | Elevated | Healthcare | Japan | 5 / 6 | $9M |
| Marinomed Biotech AG MARI.VI | 37 | Normal | Healthcare | Austria | 5 / 6 | $9M |
| Virax Biolabs Group Ltd - Class A VRAX | 42 | Elevated | Healthcare | United Kingdom | 4 / 6 | $9M |
| Asia Vets Holdings Ltd. 5RE.SI | 38 | Normal | Healthcare | Singapore | 5 / 6 | $9M |
| VistaGen Therapeutics Inc VTGN | 46 | Elevated | Healthcare | United States | 4 / 6 | $9M |
| Vitura Health Ltd VIT | 19 | Contained | Healthcare | Australia | 3 / 6 | $9M |
| Memphasys Limited MEM.AX | 59 | Elevated | Healthcare | Australia | 4 / 6 | $9M |
| China Healthwise Holdings Limited 0348.HK | 41 | Elevated | Healthcare | Hong Kong | 4 / 6 | $9M |
By sector
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.